Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01000558 · ClinicalTrials.gov registry record
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
A clinical trial of Lymphoma, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 939
- Enrollment target
- 20
- Study locations
NCT01000558 is a study of Lymphoma that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 939 participants, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher). The trial reports 20 study locations across 7 states.
The verdict
NCT01000558, a study of Lymphoma, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 939 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
Georgia
- Piedmont Hospital - Atlanta
- Northside Hospital Cancer Center - Atlanta
- Saint Joseph's Hospital of Atlanta - Atlanta
- CCOP - Atlanta Regional - Atlanta
- WellStar Cobb Hospital - Austell
- John B. Amos Cancer Center - Columbus
- Charles B. Eberhart Cancer Center at DeKalb Medical Center - Decatur
- Piedmont Fayette Hospital - Fayetteville
California
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center - Burbank
- Peninsula Medical Center - Burlingame
- North Bay Cancer Center - Fairfield
- California Pacific Medical Center - California Campus - San Francisco
- Sutter Health - Western Division Cancer Research Group - San Rafael
- Sutter Solano Medical Center - Vallejo
Alabama
- Providence Cancer Center at Providence Hospital - Mobile
Alaska
- Alaska Regional Hospital Cancer Center - Anchorage
Arkansas
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
Connecticut
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford
Florida
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 939 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01000558
The ClinicalTrials.gov registry entry for NCT01000558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 939 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT01000558 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Georgia, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT01000558 about?
NCT01000558 is a clinical study titled "SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma". RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
What is the current status of trial NCT01000558?
This trial is currently completed. The enrollment target is 939 participants. The study started on 2005-03. Estimated completion is 2011-07.
What conditions does trial NCT01000558 study?
This clinical trial studies the following conditions: Lymphoma.
What interventions are being tested in trial NCT01000558?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT01000558?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01000558 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.